Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,802 | 25,741 | 18,386 | 20,450 | 28,677 |
| Marketable Securities | 33,481 | 45,149 | 48,961 | 51,074 | 51,732 |
| Receivables | 78,881 | 67,039 | 73,708 | 65,322 | 60,137 |
| Inventories | 53,160 | 45,950 | 42,864 | 42,473 | 42,110 |
| TOTAL | $209,014 | $195,187 | $191,168 | $185,903 | $188,774 |
| Non-Current Assets | |||||
| PPE Net | 14,863 | 15,414 | 15,900 | 19,306 | 20,166 |
| Other Non-Current Assets | 9,270 | 10,176 | 11,068 | 12,678 | 13,566 |
| TOTAL | $24,133 | $25,590 | $26,968 | $31,984 | $33,732 |
| Total Assets | $233,147 | $220,777 | $218,136 | $217,887 | $222,506 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,709 | 10,188 | 10,226 | 837 | 3,240 |
| Accrued Expenses | 34,956 | 31,390 | 24,639 | 27,590 | 31,515 |
| TOTAL | $91,457 | $85,544 | $80,317 | $75,378 | $79,685 |
| Non-Current Liabilities | |||||
| Long Term Debt | 25,026 | 24,828 | 24,634 | 24,447 | 24,263 |
| Other Non-Current Liabilities | 150,315 | 150,410 | 151,125 | 151,828 | 152,531 |
| TOTAL | $175,341 | $175,238 | $175,759 | $176,275 | $176,794 |
| Total Liabilities | $266,798 | $260,782 | $256,076 | $251,653 | $256,479 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 152,330 | 152,095 | 151,668 | 150,653 | 150,329 |
| Common Shares | 1,521 | 1,517 | 1,516 | 1,504 | 1,503 |
| Retained earnings | -1,919,594 | -1,923,257 | -1,918,409 | -1,909,174 | -1,906,014 |
| Other shareholders' equity | 13 | 40 | -8 | -6 | 13 |
| TOTAL | $-33,651 | $-40,005 | $-37,940 | $-33,766 | $-33,973 |
| Total Liabilities And Equity | $233,147 | $220,777 | $218,136 | $217,887 | $222,506 |